Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3748/wjg.v27.i6.449 http://scihub22266oqcxt.onion/10.3748/wjg.v27.i6.449 33642821!7896435!33642821     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Gastroenterol 2021 ; 27 (6): 449-469 Nephropedia Template TP {{tp|p=33642821|t=2021. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings |pdf=|usr=}}{{33642821}} gab.com Text Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings JO: World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=33642821 #FOAvip The novel coronavirus disease-2019 (COVID-19) is caused by a positive-sense single-stranded RNA virus which belongs to the Coronaviridae family. In March 2019 the World Health Organization declared that COVID-19 was a pandemic. COVID-19 patients typically have a fever, dry cough, dyspnea, fatigue, and anosmia. Some patients also report gastrointestinal (GI) symptoms, including diarrhea, nausea, vomiting, and abdominal pain, as well as liver enzyme abnormalities. Surprisingly, many studies have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA in rectal swabs and stool specimens of asymptomatic COVID-19 patients. In addition, viral receptor angiotensin-converting enzyme 2 and transmembrane protease serine-type 2, were also found to be highly expressed in gastrointestinal epithelial cells of the intestinal mucosa. Furthermore, SARS-CoV-2 can dynamically infect and replicate in both GI and liver cells. Taken together these results indicate that the GI tract is a potential target of SARS-CoV-2. Therefore, the present review summarizes the vital information available to date on COVID-19 and its impact on GI aspects. Twit Text FOAVip Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings ????World J Gastroenterol http://www.kidney.de/pget.php?&tw=1&pmid=33642821 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33642821 #FOAvip English Wikipedia <ref>{{Cite pmid|33642821}}</ref> Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings #MMPMID33642821 Sahu T; Mehta A; Ratre YK; Jaiswal A; Vishvakarma NK; Bhaskar LVKS; Verma HK World J Gastroenterol 2021[Feb]; 27 (6): 449-469 PMID33642821show ga The novel coronavirus disease-2019 (COVID-19) is caused by a positive-sense single-stranded RNA virus which belongs to the Coronaviridae family. In March 2019 the World Health Organization declared that COVID-19 was a pandemic. COVID-19 patients typically have a fever, dry cough, dyspnea, fatigue, and anosmia. Some patients also report gastrointestinal (GI) symptoms, including diarrhea, nausea, vomiting, and abdominal pain, as well as liver enzyme abnormalities. Surprisingly, many studies have found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral RNA in rectal swabs and stool specimens of asymptomatic COVID-19 patients. In addition, viral receptor angiotensin-converting enzyme 2 and transmembrane protease serine-type 2, were also found to be highly expressed in gastrointestinal epithelial cells of the intestinal mucosa. Furthermore, SARS-CoV-2 can dynamically infect and replicate in both GI and liver cells. Taken together these results indicate that the GI tract is a potential target of SARS-CoV-2. Therefore, the present review summarizes the vital information available to date on COVID-19 and its impact on GI aspects. |COVID-19/*complications/diagnosis[MESH] |Endoscopy, Gastrointestinal[MESH] |Gastrointestinal Diseases/diagnosis/*virology[MESH] |Host-Pathogen Interactions[MESH] |Humans[MESH] |Liver Diseases/complications/*therapy[MESH]Current understanding of the impact of COVID-19 on gastrointestinal di(epmc).pdf DeepDyve Pubget Overpricing